Royalty Pharma shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Royalty Pharma
Tip: Access up to 7 years of quarterly data
All positions including Royalty Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Royalty Pharma by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $42M | 1.5M | 28.09 |
2023-09-30 | $37M | 1.3M | 27.14 |
2023-06-30 | $42M | 1.2M | 36.03 |
2023-03-31 | $42M | 1.2M | 36.03 |
2022-12-31 | $43M | 1.1M | 39.52 |
2022-09-30 | $41M | 1.0M | 40.18 |
2022-06-30 | $39M | 937k | 42.04 |
2022-03-31 | $37M | 938k | 38.96 |
2021-12-31 | $37M | 916k | 39.85 |
2021-09-30 | $21M | 590k | 36.14 |
2021-06-30 | $24M | 573k | 40.99 |
2021-03-31 | $23M | 518k | 43.62 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas